Miromatrix Medical Inc. Common Stock
MIRO
MIRO was delisted on the 12th of December, 2023.
21 hedge funds and large institutions have $39.1M invested in Miromatrix Medical Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIPM
G2 Investment Partners Management
New York
|
+$7.84M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$6.12M |
| 3 |
GS
Gagnon Securities
New York
|
+$5.61M |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$3.86M |
| 5 |
RI
RTW Investments
New York
|
+$3.6M |
Top Sellers
MIRO Hedge Fund Activity: Q2 2021 in Review
21 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Miromatrix Medical Inc. Common Stock (MIRO) for Q2 2021, worth a combined $39.1M.
Buyers outnumbered sellers: 21 funds opened new MIRO positions and 0 closed out — a net gain of 21 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was G2 Investment Partners Management, opening a new position worth an estimated $7.84M.
- 21 institutional investors held Miromatrix Medical Inc. Common Stock (MIRO) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $39.1M of Miromatrix Medical Inc. Common Stock stock for Q2 2021.
- 21 funds opened new Miromatrix Medical Inc. Common Stock positions in Q2 2021 and 0 closed out, a net change of +21 holders.
- The largest Miromatrix Medical Inc. Common Stock buyer in Q2 2021 was G2 Investment Partners Management, an estimated $7.84M added.
Based on aggregated 13F filings for Q2 2021.